Mereo BioPharma Group Plc (MREO)
0.2672
-0.01
(-3.43%)
USD |
NASDAQ |
Sep 02, 16:00
0.2686
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Research and Development Expense (TTM) : 14.98M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.98M |
| March 31, 2026 | 18.61M |
| December 31, 2025 | 17.81M |
| September 30, 2025 | 22.37M |
| Date | Value |
|---|---|
| June 30, 2025 | 21.33M |
| March 31, 2025 | 20.84M |
| December 31, 2024 | 20.88M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 12.59M |
| BioNTech SE | 2.414B |
| Silence Therapeutics Plc | 43.54M |
| Autolus Therapeutics Plc | 112.42M |